Tianmi Capital

The firm focuses on early-stage venture capital and growth equity, primarily participating in Series A through Series C rounds. Tianmi Capital often acts as a lead or co-lead investor, targeting companies that have demonstrated initial product-market fit and require capital to scale within China's domestic market.

Tianmi Capital invests primarily in enterprise technology, consumer internet, and healthcare innovation. The firm's Shanghai base gives it proximity to China's most active startup ecosystem, and it concentrates on sectors where local market knowledge and regulatory understanding provide a genuine edge.

The firm leverages a relationship-driven sourcing model rooted in Shanghai's dense technology and venture networks. Rather than relying on auction processes or broad inbound deal flow, Tianmi Capital builds direct relationships with founders early — often before formal fundraising processes begin.

The firm operates with a leaner, more concentrated approach than large institutional China funds. Without the pressure to deploy massive fund sizes, Tianmi Capital can be selective, leading or co-leading rounds with a partnership-first mentality that prioritizes founder alignment over pure check size.